SCHEMBL2226689

SCHEMBL2226689

COc1ccc(C(=N)NO)cc1C(=O)O

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 1/20 0.50
CA12 O43570 1/20 0.49
CA1 P00915 1/20 0.49
CA2 P00918 1/20 0.49
CA4 P22748 1/20 0.49
CA6 P23280 1/20 0.49
CA7 P43166 1/20 0.49
TPMT P51580 1/20 0.49
CA9 Q16790 1/20 0.49
CA14 Q9ULX7 1/20 0.49
LCK P06239 1/20 0.47
FYN P06241 1/20 0.47
HDAC8 Q9BY41 4/20 0.47
AKR1C3 P42330 1/20 0.47
AKR1C2 P52895 1/20 0.47
ALDH1A1 P00352 3/20 0.47
HDAC1 Q13547 2/20 0.46
HDAC6 Q9UBN7 2/20 0.46
HTT P42858 3/20 0.45
HPGD P15428 2/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22396445 0.84 HDAC1 (0.46) POLBHDAC8AKR1C3AKR1C2ALDH1A1
SCHEMBL901309 0.81 CA12 (0.71) POLBCA12CA1CA2CA4
SCHEMBL29446743 0.81 CA12 (0.71) POLBCA12CA1CA2CA4
SCHEMBL22396389 0.81 ALOX15 (0.42) AKR1C3AKR1C2ALDH1A1HTTLMNA
SCHEMBL310059 0.80 MAPT (0.60) POLBCA12CA1CA2CA4
SCHEMBL22396400 0.80 TPMT (0.47) POLBCA12CA1CA2CA4
Hydrochloric Acid SCHEMBL11840020 0.80 CA12 (0.69) POLBCA12CA1CA2CA4
SCHEMBL28007167 0.80 CA12 (0.69) POLBCA12CA1CA2CA4
SCHEMBL4221619 0.80 CYP2C9 (0.55) POLBCA12CA1CA2CA4
SCHEMBL12171083 0.79 RAB9A (0.54) POLBAKR1C3AKR1C2ALDH1A1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3704113-A1 BRIDGED BICYCLIC COMPOUNDS AS FARNESOID X RECEPTOR MODULATORS Bristol-Myers Squibb Company (US) 2020-09-09 EP disclosed
WO-2011088181-A9 COMPOUNDS AND METHODS TEMPERO PHARMACEUTICALS, INC. (US) 2013-01-31 WO disclosed
EP-2533783-A1 COMPOUNDS AND METHODS Tempero Pharmaceuticals, Inc. (US) 2012-12-19 EP disclosed
WO-2011088181-A1 COMPOUNDS AND METHODS TEMPERO PHARMACEUTICALS, INC. (US) 2011-07-21 WO disclosed